Context Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-270,000
Closed -$2.82M 270
2020
Q3
$2.82M Buy
+270,000
New +$2.82M 0.61% 62